BIOCHEMICAL BONE MARKERS AS PREDICTORS OF BONE LOSSES FOLLOWING LIVER TRANSPLANTATION
https://doi.org/10.15825/1995-1191-2010-3-52-61
Abstract
24 recipients after ortotopic liver transplantation (9 women and 5 men) 18–57 years aged were studied in 1–2 and then through 4–18 months following operation. Bone mineral density (BMD) in repeated estimation in 13 recipients was elevated on 14 ± 10,5% and in 11 recipients was decreased on 2,5 ± 2,56%. BMD elevation was associated with bone remodelling normalization. BMD lowering followed transplant dysfunction, glucocorticoid therapy, bone resorption increasing and bone formation suppression.
About the Authors
V. P. Buzulina
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moskow
Russian Federation
Russian Federation
I. A. Pronchenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moskow
Russian Federation
Russian Federation
I. P. Yermakova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moskow
Russian Federation
Russian Federation
E. B. Yaroshenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moskow
Russian Federation
Russian Federation
M. N. Kornilov
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moskow
Russian Federation
Russian Federation
N. P. Shmerko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moskow
Russian Federation
Russian Federation
References
1. Atamaz F., Hepculer S., Akuildiz M., Karasu Z. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation // Osteopo- ros. Int. 2006. Vol. 17. P. 942–949.
2. Bjoro K., Brandsaeter B., Wiencke K. et al. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver dis- ease // Scand. J. Gastroenterol. 2003. Vol. 38. P. 320– 327.
3. Collier J. Bone disorders in chronic liver disease // Hepa- tology. 2007. Vol. 46. P. 1271–1278.
4. Crawford B.A.L., Kam C., Donaghy A.J., McCaug- han G.W. The heterogeneity of bone disease in cirrhosis: a multivariate analysis // Osteoporos. Int. 2003. Vol. 14. P. 987–994.
5. Crawford B.A.L., Kam C., Pavlovic J., Byth K. et al. Zoledronic acid prevents bone loss after liver transplan- tation //Ann. Intern. Med. 2006. Vol. 144. P. 239–248.
6. Compston J.E. Osteoporosis after liver transplantation // Liver. Transpl. 2003. Vol. 9. P. 321–330.
7. Crosbie O.M., Freaney R., McKenna M.J., Curry M.P., Hegarty J.E. Bone density, vitamin D status, and disor- dered bone remodeling in end-stage chronic liver disease // Calcif. Tissue. Intern. 1999. Vol. 64. P. 295–300.
8. Floreani A., Mega A., Tizian L., Burra P. et al. Bone me- tabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study // Os- teoporos. Int. 2001. Vol. 12. P. 749–754.
9. Giannini S., Nobile M., Ciuffreda M., Iemmolo R.M. et al. Long-term persistence of low bone density in orthotopic liver transplantation // Osteoporos Int. 2000. Vol. 11. P. 417–424.
10. Guichelaar M.M.J., Malinchoc M., Sibonga J. et al. Immunosuppression and other posttransplant effects of bone metabolism // Liver. Transpl. 2004. Vol. 10. P. 638– 647.
11. Guichelaar M.M.J., Kendall R., Malinchoc M., Hay J.E. et al. Bone mineral density before and after OLT: long- term follow-up and predictive factors // Liver Transplan- tation. 2006. Vol. 12. P. 1390–1402.
12. Hamburg S.M., Piers D.A., van den Berg A.P. et al. Bone mineral density in long term after liver transplantation // Osteoporos. Int. 2000. Vol. 11. P. 600–606.
13. de Kroon L., Drent G., van den Berg A.P., Haagsma E.B. Current health status of patients who have survived for
14. more 15 years after liver transplantation // The Nitherlands Journal of Medicine. 2007. Vol. 65. P. 252–258.
15. McDonald J.A., Dunstan C.R., Dilworth P., Sherbon K. et al. Bone loss after liver transplantation // Hepatology.
16. Vol. 14. P. 50–55.
17. Monegal A., Navasa M., Guanabens N., Peris P. et al. Bone disease after liver transplantation: a long-term pro- spective study of bone mass changes, hormonal disorders and histomorphometric characteristics // Osteoporos. Int. 2001. Vol. 12. P. 484–492.
18. Monegal A., Navasa M., Guanabens N., Peris P. et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A // Calcif. Tissue. Int. 2001. Vol. 68. P. 83–86.
19. Mounach A., Ouzzif Z., Wariaghli G., Achemlal L. et al. Primary biliary cirrhosis and osteoporosis: a case-control study // J. Bone. Miner. Metab. 2008. Vol. 26. P. 379–384.
20. Vedi S., Greer S., Skingle S.J., Garrahan N.J. et al. Mechanism of bone loss after liver transplantation: a his- tomorphometric analysis // J. Bone. Miner. Res. 1999. Vol. 14. P. 281–287.
Review
For citations:
Buzulina V.P., Pronchenko I.A., Yermakova I.P., Yaroshenko E.B., Kornilov M.N., Shmerko N.P. BIOCHEMICAL BONE MARKERS AS PREDICTORS OF BONE LOSSES FOLLOWING LIVER TRANSPLANTATION. Russian Journal of Transplantology and Artificial Organs. 2010;12(3):52-61. (In Russ.) https://doi.org/10.15825/1995-1191-2010-3-52-61
Views:
708
Email this article 